LONG-TERM IMPLANTABLE BIOSENSOR

• US 20110282172A1
• Filed: 11/09/2009
• Published: 11/17/2011
• Est. Priority Date: 11/11/2008
• Status: Abandoned Application

• Current Assignee: Konamite Limited
• Original Assignee: Isense Corporation
• Inventors: Sass, Richard G.
• Application Number:
  US13/127,708
• Publication Number:
  US 20110282172A1
• Time in Patent Office: Days
• US Class Current: 600/347
• CPC Class Codes: A61B 5/076 Permanent implantations telemetry using implanted circuitry A61B5/0031; implanted stimulators for therapy A61N1/3605, A61N1/362, A61N1/372
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14865 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors

Abstract

Embodiments provide an analyte sensing device having one or more indicating electrodes adapted for long-term use within an individual. An indicating electrode coupled with a reference electrode may be inserted within or below the dermis of an individual and may be electrically coupled to an external sensor unit. Related analyte sensor insertion aids and methods of using the disclosed embodiments are also provided.

Claims

1. An analyte sensing assembly, comprising:

an elongated indicating electrode configured for insertion below a mammalian epidermis, wherein the indicating electrode comprises a first core and a first layer of electrochemically active metal surrounding and in contact with an outer surface of the core; and

an elongated reference electrode configured for insertion below a mammalian epidermis, wherein the reference electrode comprises a second core and a second layer of electrochemically active metal surrounding and in contact with an outer surface of the core,

wherein the indicating electrode and the reference electrode are coupled along at least a portion of their lengths.

2. The analyte sensing assembly of claim 1, wherein the indicating electrode and the reference electrode are entwined along at least a portion of their lengths.

3. The analyte sensing assembly of claim 1, wherein the indicating electrode and the reference electrode are helically entwined along at least a portion of their lengths.

4. The analyte sensing assembly of claim 1, wherein the first and second core each comprise at least one of silicone and expanded polytetrafluoroethylene.

5. The analyte sensing assembly of claim 1, wherein the first layer of electrochemically active metal is configured to provide at least one sensing surface.

6. The analyte sensing assembly of claim 1, wherein the first layer of electrochemically active metal is at least partially surrounded by a membrane system.

7. The analyte sensing assembly of claim 6, wherein the membrane system is configured to sense glucose.

8. The analyte sensing assembly of claim 3, further including a first sensor contact element coupled to the first layer of electrochemically active metal.

9. The analyte sensing assembly of claim 8, further including a second sensor contact element coupled to the second layer of electrochemically active metal.

10. The analyte sensing assembly of claim 9, wherein the first sensor contact and the second sensor contact are configured to be retained beneath a mammalian epidermis.

11. An analyte sensing system, comprising:

an analyte sensor assembly configured to be retained beneath an epidermis of a body when in use, comprising an indicating electrode and a reference electrode, wherein the indicating electrode and the reference electrode are helically entwined along some portion of their lengths; and

an analyte sensor module configured to removably couple with the analyte sensor assembly.

12. The analyte sensing system of claim 11, wherein the analyte sensor module is configured to be mounted on the outer surface of the skin of an individual.

13. The analyte sensing system of claim 11, further including a first sensor contact coupled to the indicating electrode and adapted to pivot in relation to a point of attachment to the indicating electrode, and a second sensor contact coupled to the reference electrode and adapted to pivot in relation to a point of attachment to the reference electrode.

14. The analyte sensing system of claim 11, wherein the analyte sensor module comprises an adhesive patch.

15. The analyte sensing system of claim 11, wherein the analyte sensor module is configured to inductively couple with the analyte sensor assembly.

16. The analyte sensing system of claim 11, wherein the analyte sensor module further includes along a bottom surface at least one downward projection configured to be retained at least partially within the epidermis.

17. The analyte sensing system of claim 11, further including a first sensor contact coupled to the indicating electrode, and a second sensor contact coupled to the reference electrode.

18. The analyte sensing system of claim 17, wherein the analyte sensor module further includes along a bottom surface at least one downward projection configured to be retained at least partially within the epidermis, wherein each of the at least one downward projection is coupled to either the first sensor contact or the second sensor contact.

19. The analyte sensing system of claim 11 wherein the analyte sensor module is configured to receive electromagnetic signals from the analyte sensor assembly.

20. The analyte sensing system of claim 11 wherein the analyte sensor module is inductively coupled to the analyte sensor assembly.

21. A method for monitoring an analyte within a body having an epidermis, comprising:

inserting within a body an analyte sensing element including an elongated indicating electrode surrounded at least partially by an insulating layer, and an elongated reference electrode, wherein the indicating electrode and the reference electrode are entwined along at least a portion of their lengths;

placing a sensor module above the epidermis of the body in proximity to the analyte sensing element;

coupling the analyte sensing element and the sensor module; and

receiving by the sensor module a signal indicative of a concentration of analyte within the body.

22. The method of claim 21, further including retaining the analyte sensing element below the epidermis for a duration of more than ten days.